Low-dose aspirin for the prevention of preterm birth in nulliparous women: systematic review and meta-analysis.

ABSTRACT:

Objective

The objective was to assess the efficacy and safety of low-dose aspirin for the prevention of preterm birth in nulliparous women.

Data sources

We searched PubMed, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception to June 2022.

Study eligibility criteria

Randomized controlled trials that compared aspirin to placebo in nulliparous women were eligible.

Methods

This study was reported in accordance with the PRISMA 2020 checklist. The primary outcomes of this study were the rates of preterm birth at less than 37 weeks and less than 34 weeks of gestation. The secondary outcomes included postpartum hemorrhage, placental abruption, cesarean section, any hypertensive disorder of pregnancy and small for gestational age. Rela

SUBMITTER: Yan X 

PROVIDER: S-EPMC11008052 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature